SIREN : 803757038
VA PROTHESES is a French company founded 11 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LIVRY-GARGAN (93190), this company of category PME shows in 2023 a revenue of 239 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 238 593 € | 209 479 € | 183 164 € |
| Net income | 17 677 € | 32 802 € | 33 019 € |
| EBITDA | 30 596 € | 40 211 € | 40 009 € |
| Net margin | 7.4% | 15.7% | 18.0% |
In 2023, VA PROTHESES achieves revenue of 239 k€. Over the period 2021-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +14.1%. Vs 2022, growth of +14% (209 k€ -> 239 k€). After deducting consumption (0 €), gross margin stands at 239 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 31 k€, representing 12.8% of revenue. Warning negative scissor effect: despite revenue change (+14%), EBITDA varies by -24%, reducing margin by 6.4 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 18 k€, i.e. 7.4% of revenue. This profit can be retained or distributed to shareholders.
238 593 €
238 593 €
30 596 €
20 797 €
17 677 €
12.4%
The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 11.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
45.568%
55.744%
11.166%
2.101
4.6%
In 2023, the debt ratio of VA PROTHESES (45.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of VA PROTHESES (55.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2023, the repayment capacity of VA PROTHESES (2.10) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 468.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
468.152
0.0
In 2023, the liquidity ratio of VA PROTHESES (468.15) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2023, the interest coverage of VA PROTHESES (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 25 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 36 days. Favorable situation: supplier credit is longer than customer credit by 11 days. Inventory turnover is 3 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. WCR is negative (-1 days): operations structurally generate cash. Over 2021-2023, WCR increased by +93%, requiring additional financing.
-697 €
25 j
36 j
3 j
-1 j
Based on 57 transactions of similar company sales
(all years),
the value of VA PROTHESES is estimated at
65 848 €
(range 17 681€ - 127 040€).
With an EBITDA of 30 596€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare VA PROTHESES with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of VA PROTHESES in 2023 is 239 k€.
Yes, VA PROTHESES generated a net profit of 18 k€ in 2023.
The headquarters of VA PROTHESES is located in LIVRY-GARGAN (93190), in the department Seine-Saint-Denis.
The tax return of VA PROTHESES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
VA PROTHESES operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.